Skip to main content

Peer Review reports

From: Long-term safety and efficacy of vismodegib in patients with advanced basal cell carcinoma: final update of the pivotal ERIVANCE BCC study

Original Submission
7 Dec 2016 Submitted Original manuscript
17 Feb 2017 Author responded Author comments - Aleksandar Sekulic
28 Dec 2016 Reviewed Reviewer Report - Matthew Old
16 Jan 2017 Reviewed Reviewer Report - Sapna Patel
Resubmission - Version 2
17 Feb 2017 Submitted Manuscript version 2
24 Mar 2017 Author responded Author comments - Aleksandar Sekulic
Resubmission - Version 3
24 Mar 2017 Submitted Manuscript version 3
10 Apr 2017 Author responded Author comments - Aleksandar Sekulic
Resubmission - Version 4
10 Apr 2017 Submitted Manuscript version 4
Publishing
19 Apr 2017 Editorially accepted
16 May 2017 Article published 10.1186/s12885-017-3286-5

You can find further information about peer review here.

Back to article page